Agenda

Day 1: Friday, August 16 All times in Eastern Time
12:30 pm	Registration & Exhibits
1:00 pm	Welcome/Introduction Truong
Session 1: New Approaches to Melanoma Diagnosis, Risk Assessment, and Screening Moderator: Josh Arbesman, MD, Jennifer Ko, MD, James Isaacs, MD, Surgery: Anthony Tufaro, DDS, MD, FACS, Gowri Kabbur, MD
1:05 pm	Case Presentations Ko/Arbesman/Isaacs
1:25 pm	Liquid Biopsy in the Diagnosis of Advanced Melanoma Ko
1:45 pm	New Approaches to Melanoma Risk Calculation Arbesman
2:05 pm	Case Presentations Con’t/Panel Discussion Drs. Arbesman, Ko, Isaacs, Tufaro, Truong, Kabbur
2:30 pm	Break & Exhibits
Session 2: Modern Peri-operative Management Moderator: Anthony Tufaro, MD, Thach-Giao Truong, MD, Luke Rothermel, MD, Ankit Mangla, MD, Neil Woody, MD, Anthony Visioni, MD
2:45 pm	Surgical Management of Resectable High-Risk Melanoma/Index Node vs Node Dissection Following MPR with Neoadjuvant Therapy Mammen
3:05 pm	Surgical Management of Clinically Node-Negative Melanoma Tufaro
3:25 pm	Peri-operative Systemic Therapy for Resectable Melanoma/Neoadjuvant vs Adjuvant Therapy Truong
3:45 pm	Case Presentations/Panel Discussion Drs. Tufaro, Truong, Mammen, Visioni, Rothermel, Mangla, Woody, Sam Guild
4:05 pm	Break & Exhibits
Session 3: What is the Best Frontline Therapy for Advanced Melanoma? A Debate Session Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Evan Lipson, MD, Ankit Mangla, MD
4:20 pm	Immunotherapy Combos in 1L Evan Lipson
4:40 pm	Targeted Therapy Combos 1L Jim Isaacs
5:00 pm	Panel Discussion/Q&A Isaacs, Truong, Lipson, Mangla, Guild
5:30 pm	Day 1 Closing Remarks
5:35 pm	Networking Cocktail Hour (open to all attendees, faculty, sponsors)

8:00 am

Breakfast/Registration

Optional Non-Accredited Patient Symposium
A Collaboration with AIM at Melanoma Foundation in the AM

8:30 am	Welcome Truong
8:35 am	Tips on Recovering After Surgery Hannah Burke, NP
8:55 am	Recent Approvals and Clinical Trials in Melanoma Truong/Isaacs
9:15 am	What to Expect When You Are on Melanoma Immunotherapy Kennedy
9:35 am	Managing Your Treatment on BRAF/MEK Therapy Chheng
9:55 am	Peri-operative Patient Survivor Panel Q/A
10:15 am	Break
10:30 am	Long-Term Survivorship After Stage IV Diagnosis Kuhn
10:45 am	Prevention and Self-Screening, How to Take Charge of Your Care Wickenheiser
11:05 am	Wellness at Taussig Throughout Your Melanoma Journey Taussig Patient Resources Team
11:20 am	Stage IV Patient Survivor Panel Q/A
11:45 am	How to Build Your Melanoma Community: A Conversation with Guild
12:00 pm	AM Wrap-Up/Closing Remarks Truong/Guild

12:05 pm

Networking Lunch (open to all--patients, attendees, faculty, sponsors)

Session 4: Uveal Melanoma
Moderator: Lucy Boyce Kennedy, MD, Arun Singh, MD, Marlana Orloff, MD, Ankit Mangla, MD

12:45 pm

Early-Stage Local Management of UM
Singh

1:05 pm

Updates in Standard Systemic Therapy for UM
Kennedy

1:25 pm

Novel Therapeutic Strategies in Uveal Melanoma
Orloff

1:45 pm

Case Presentations/Panel Discussion
Singh, Kennedy, Orloff, Truong, Mangla

Session 5: Brain Metastases in Melanoma
Moderator: Lucy Boyce Kennedy, MD, Samuel Chao, MD, Kim Margolin, MD

2:05 pm

Local Treatment Options and Combinations for Melanoma Brain Metastases
Chao

2:25 pm

Frontline Therapy for Patients with Brain Metastases
Kennedy

2:45 pm

Novel Systemic Treatment Options in CNS
Margolin

3:05 pm

Cases/Panel Discussion/Q&A
Kennedy, Margolin, Chao, Orloff, Truong, Guild

3:25 pm

Break

Session 6: What Are Our Post-PD1 Options Now for Metastatic Melanoma?
Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Diwakar Davar, MD

3:40 pm

IO Combination Therapy vs TIL in 2L
Isaacs

4:00 pm

Microbiome and Other Metabolic Strategies in Melanoma
Davar

4:20 pm

Promising Post-PD1 Treatment Targets
Truong

4:40 pm

Panel Discussion/Q&A
Isaacs, Truong, Davar, Kennedy, Mangla

Closing Panel: New Directions in Multidisciplinary Melanoma Care
Panelists: Thach-Giao Truong, MD, Sam Guild, Neil Woody, MD, Anthony Tufaro, DDS, MD, FACS, Kim Margolin, MD

5:00 pm

Panel Discussion

Agenda

Day 1: Friday, August 16
All times in Eastern Time

Session 1: New Approaches to Melanoma Diagnosis, Risk Assessment, and Screening
Moderator: Josh Arbesman, MD, Jennifer Ko, MD, James Isaacs, MD, Surgery: Anthony Tufaro, DDS, MD, FACS, Gowri Kabbur, MD

Session 2: Modern Peri-operative Management
Moderator: Anthony Tufaro, MD, Thach-Giao Truong, MD, Luke Rothermel, MD, Ankit Mangla, MD, Neil Woody, MD, Anthony Visioni, MD

Session 3: What is the Best Frontline Therapy for Advanced Melanoma? A Debate Session
Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Evan Lipson, MD, Ankit Mangla, MD

Day 2: Saturday, August 17
All times in Eastern Time

Optional Non-Accredited Patient Symposium
A Collaboration with AIM at Melanoma Foundation in the AM

Session 4: Uveal Melanoma
Moderator: Lucy Boyce Kennedy, MD, Arun Singh, MD, Marlana Orloff, MD, Ankit Mangla, MD

Session 5: Brain Metastases in Melanoma
Moderator: Lucy Boyce Kennedy, MD, Samuel Chao, MD, Kim Margolin, MD

Session 6: What Are Our Post-PD1 Options Now for Metastatic Melanoma?
Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Diwakar Davar, MD

Closing Panel: New Directions in Multidisciplinary Melanoma Care
Panelists: Thach-Giao Truong, MD, Sam Guild, Neil Woody, MD, Anthony Tufaro, DDS, MD, FACS, Kim Margolin, MD

Agenda

Day 1: Friday, August 16 All times in Eastern Time

Session 1: New Approaches to Melanoma Diagnosis, Risk Assessment, and Screening Moderator: Josh Arbesman, MD, Jennifer Ko, MD, James Isaacs, MD, Surgery: Anthony Tufaro, DDS, MD, FACS, Gowri Kabbur, MD

Session 2: Modern Peri-operative Management Moderator: Anthony Tufaro, MD, Thach-Giao Truong, MD, Luke Rothermel, MD, Ankit Mangla, MD, Neil Woody, MD, Anthony Visioni, MD

Session 3: What is the Best Frontline Therapy for Advanced Melanoma? A Debate Session Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Evan Lipson, MD, Ankit Mangla, MD

Day 2: Saturday, August 17 All times in Eastern Time

Optional Non-Accredited Patient Symposium A Collaboration with AIM at Melanoma Foundation in the AM

Session 4: Uveal Melanoma Moderator: Lucy Boyce Kennedy, MD, Arun Singh, MD, Marlana Orloff, MD, Ankit Mangla, MD

Session 5: Brain Metastases in Melanoma Moderator: Lucy Boyce Kennedy, MD, Samuel Chao, MD, Kim Margolin, MD

Session 6: What Are Our Post-PD1 Options Now for Metastatic Melanoma? Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Diwakar Davar, MD

Closing Panel: New Directions in Multidisciplinary Melanoma Care Panelists: Thach-Giao Truong, MD, Sam Guild, Neil Woody, MD, Anthony Tufaro, DDS, MD, FACS, Kim Margolin, MD

Day 1: Friday, August 16
All times in Eastern Time

Session 1: New Approaches to Melanoma Diagnosis, Risk Assessment, and Screening
Moderator: Josh Arbesman, MD, Jennifer Ko, MD, James Isaacs, MD, Surgery: Anthony Tufaro, DDS, MD, FACS, Gowri Kabbur, MD

Session 2: Modern Peri-operative Management
Moderator: Anthony Tufaro, MD, Thach-Giao Truong, MD, Luke Rothermel, MD, Ankit Mangla, MD, Neil Woody, MD, Anthony Visioni, MD

Session 3: What is the Best Frontline Therapy for Advanced Melanoma? A Debate Session
Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Evan Lipson, MD, Ankit Mangla, MD

Day 2: Saturday, August 17
All times in Eastern Time

Optional Non-Accredited Patient Symposium
A Collaboration with AIM at Melanoma Foundation in the AM

Session 4: Uveal Melanoma
Moderator: Lucy Boyce Kennedy, MD, Arun Singh, MD, Marlana Orloff, MD, Ankit Mangla, MD

Session 5: Brain Metastases in Melanoma
Moderator: Lucy Boyce Kennedy, MD, Samuel Chao, MD, Kim Margolin, MD

Session 6: What Are Our Post-PD1 Options Now for Metastatic Melanoma?
Moderator: Jim Isaacs, MD, Thach-Giao Truong, MD, Diwakar Davar, MD

Closing Panel: New Directions in Multidisciplinary Melanoma Care
Panelists: Thach-Giao Truong, MD, Sam Guild, Neil Woody, MD, Anthony Tufaro, DDS, MD, FACS, Kim Margolin, MD